Pricing Log in Create free account

Haleon PLC Sponsored ADR (HLN) vs United Therapeutics Corporation (UTHR)

Haleon PLC Sponsored ADR and United Therapeutics Corporation are both Drug Manufacturers Specialty & Generic companies. Haleon PLC Sponsored ADR is the larger, with a market value of $43.7B against $23.2B — 1.9× the size. United Therapeutics Corporation trades at the lower P/E: 17.6× against 22.6×. United Therapeutics Corporation has the higher net margin (41.6% vs 13.8%) and the higher return on invested capital (23.4% vs 0.00%). Across the 21 metrics below, United Therapeutics Corporation leads on 14 and Haleon PLC Sponsored ADR on 7.

Valuation

Metric HLN UTHR Drug Manufacturers Specialty & Generic median
P/E 22.58 17.61 19.25
P/S 2.57 7.20 2.11
P/B 2.11 3.55 1.78
Price to free cash flow 10.24 20.88 16.14
EV/EBITDA 13.30 13.63 12.58
EV/Sales 3.12 6.45 2.73
Earnings yield 4.43% 5.68% (4.38%)
Free cash flow yield 9.77% 4.79% 0.00%

Profitability

Metric HLN UTHR Drug Manufacturers Specialty & Generic median
Gross margin 62.22% 86.14% 53.94%
Operating margin 17.93% 44.44% 0.00%
Net margin 13.79% 41.56% 0.00%
Free cash flow margin 0.00% 34.65% 0.00%
Return on equity 0.00% 19.32% (0.40%)
Return on assets 0.00% 17.33% (3.32%)
Return on invested capital 0.00% 23.44% 0.00%

Growth

Metric HLN UTHR Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 2.49% 10.01%
EPS growth (last fiscal year) 22.50% 13.07% 49.06%
Revenue growth, 5-year CAGR 1.43% 16.50% 6.74%
Net income growth, 5-year CAGR 6.98% 20.99% 0.00%

Health

Metric HLN UTHR Drug Manufacturers Specialty & Generic median
Debt to equity 0.50 0.00 0.05
Current ratio 0.69 5.73 2.31
Net debt to EBITDA 2.63 (1.85) 0.97

Dividend

Metric HLN UTHR Drug Manufacturers Specialty & Generic median
Dividend yield 1.95% — 1.57%
Payout ratio — — 0.27

Size

Metric HLN UTHR Drug Manufacturers Specialty & Generic median
Market cap 43.71b 23.23b 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack